Gene Therapy For Rare Disease Market Size And Share

  • Report Code : TIPRE00003413
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

희귀 질환 유전자 치료 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Gene Therapy For Rare Disease Market Report Gene Therapy For Rare Disease Market Scope and Analysis Gene Therapy For Rare Disease Market Size and Share

Gene Therapy For Rare Disease Market Report Analysis

Gene Therapy For Rare Disease Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BioMarin
  • Orchard Therapeutics plc.
  • Spark Therapeutics, Inc.
  • PTC Therapeutics
  • bluebird bio, Inc.
  • Kite Pharma
  • uniQure N.V.
  • Juno Therapeutics Inc. (Celgene Corporation)
  • Novartis AG

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미
  • 중동 및 아프리카

Market Segmentation

By 치료적 적용
  • 종양학
  • 신경 장애
  • 안과 장애
  • 혈액 장애
  • 면역 결핍 장애
  • 대사 장애
  • 기타
By 지리
  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미